Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,467 public trials 2,848 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes

NCT05038592

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +14 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

NCT00840853

Conditions: Acute Lymphoblastic Leukemia (ALL), Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +19 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, not recruiting

Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A

NCT03818763

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations: Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Active, not recruiting

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

NCT04177004

Conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematologic Diseases, Hematologic Neoplasms, +4 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)

NCT03774654

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, not recruiting

Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel

NCT06523621

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Levine Cancer Institute Charlotte, North Carolina, United States

View Trial Details

Active, not recruiting

Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma

NCT04822337

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Levine Cancer Institute Charlotte, North Carolina, United States

Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Active, not recruiting

Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries Developmental Follow Up

NCT03682042

Conditions: Anemia, Anemia, Neonatal, Asphyxia Neonatorum, +20 more
Locations: KLE Academy of Higher Education and Research (Deemed-to-be-University) Jawaharlal Nehru Medical College Belagavi, Karnataka, India

Indira Gandhi Government Medical College & Hospital Nagpur, Maharashtra, India

Pimpri Chinchwad Municipal Corporation's Post-Graduate Institute, Yashwantrao Chavan Memorial Hospital Pune, Maharashtra, India

Government Medical College Chandrapur, MS, India

View Trial Details

Active, not recruiting

Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia

NCT05303792

Conditions: B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Burkitt Lymphoma, +21 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

Stanford Cancer Institute Palo Alto Palo Alto, California, United States

View all 72 locations

View Trial Details

Active, not recruiting

Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma

NCT03549442

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Univ. of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions